Advancing Molecular Research for Endometriosis Diagnosis
Veridyn Diagnostics is a research-focused molecular biology program examining endometriosis-associated molecular signals and the limitations of current diagnostic approaches. This work focuses on foundational molecular research aimed at advancing biological understanding relevant to endometriosis diagnosis.
Looking for information about endometriosis testing and diagnosis? Why diagnosing endometriosis remains so difficult.
Why Women’s Health Diagnostics Have Lagged
Conditions like endometriosis often take years to diagnose and may require invasive procedures. Imaging is frequently inconclusive, symptoms overlap across conditions, and biological changes relevant to diagnosis are difficult to distinguish using current approaches.
As a result, patients may be dismissed or misdiagnosed despite growing evidence that molecular changes precede visible disease. These challenges reflect structural gaps in diagnostic development rather than a lack of underlying scientific capability.
The Problem & the Gap
The Problem
Endometriosis and related gynecologic conditions remain difficult to diagnose, with diagnostic delays commonly reported in the range of seven to ten years and frequent reliance on invasive procedures. These prolonged diagnostic pathways contribute to uncertainty, delayed care, and significant patient burden.
The Gap
These challenges reflect structural limitations in diagnostic development rather than gaps in underlying scientific capability. Despite decades of research, diagnostic innovation in women’s health has not kept pace with advances seen in other areas of medicine.
Many tools used in current clinical workflows were not designed to reflect the biological complexity of gynecologic disease. As a result, diagnostic pathways are often prolonged, rely on invasive procedures, and provide limited insight into disease heterogeneity over time.
This gap highlights the need for foundational biological research to support future progress in women’s health diagnostics.
Why Diagnostic Timing and Specificity Matter
Delays in diagnosis can have meaningful consequences for health and quality of life. Prolonged diagnostic pathways often contribute to ongoing symptom burden and increased reliance on invasive or inconclusive procedures.
Improving how gynecologic disease is understood begins with research that better reflects underlying biology. Careful, foundational work is required before meaningful advances in diagnostics can responsibly reach clinical care.
Access, by Design
Diagnostic research should not be constrained by geography, subspecialty availability, or reliance on invasive infrastructure.
From the outset, Veridyn Diagnostics focuses on molecular research approaches intended to be compatible with real-world clinical and laboratory environments, including:
Consideration of low-burden sample types
Alignment with existing clinical and laboratory workflows
Consideration of scalability beyond specialized academic centers
Access is treated as a core design consideration from the outset, rather than a downstream implementation step.
OUR APPROACH
Building diagnostic research with discipline
Veridyn Diagnostics takes a deliberate, evidence-first approach to women’s health diagnostics. We conduct molecular research designed to reflect biological reality and support long-term scientific understanding, emphasizing interpretability, reproducibility, and clinical relevance over time.
Centering women’s biology
Gynecologic diseases such as endometriosis are complex, heterogeneous, and increasingly recognized as systemic. Our work focuses on molecular research that supports clearer biological characterization of gynecologic conditions often conflated in practice.
Reproducibility over speed
We prioritize reproducibility, transparency, and conservative interpretation throughout our research. Progress in diagnostics depends on restraint, validation, and iteration.
Scientific Foundation
Built on reproducible, data-driven research
Veridyn Diagnostics grounds its work in established molecular biology and transparent analytical practices. Our research approach emphasizes reproducibility, careful comparison, and conservative interpretation.
Our scientific foundation draws on:
Use of established, peer-reviewed biological data sources
Analytical approaches designed to support careful comparison and contextual interpretation
Statistical frameworks designed to support robustness and minimize false discovery
All work is guided by scientific rigor, transparency, and peer-review standards. This foundation supports continued research and future translational investigation, subject to appropriate validation and review.
A research foundation for future progress in women’s health diagnostics
Veridyn Diagnostics is building a molecular research foundation designed to evolve over time, beginning with gynecologic conditions where diagnostic delays have significant impact.
This work focuses on establishing rigorous biological understanding and methodological discipline that can support future advances as evidence accumulates. Emphasis is placed on reproducibility, careful validation, and alignment with real-world clinical contexts.
The long-term aim is to contribute research insights that may inform improved clinical understanding and care pathways over time, subject to appropriate validation and review.
What We’re Building Toward
From the Founder
Veridyn Diagnostics was founded to address a gap between what science already makes possible and what patients actually experience in care.
For decades, women with gynecologic disease have been told to wait for answers, for validation, and tools that reflect the biological complexity of their conditions. The scientific understanding to do better has existed, while translation into routine clinical practice has been slower.
From the beginning, Veridyn Diagnostics has taken a disciplined approach. We are building molecular diagnostics with intention. Our initial focus is on conditions where diagnostic delay causes the greatest harm. All work is grounded in reproducible, data-driven science.
We believe meaningful diagnostics must do more than generate results. They must be designed to integrate into real clinical workflows and support clearer clinical decision-making over time.
Veridyn Diagnostics is still early in this journey and that is by design. We are focused on building a foundation that is scientifically sound, clinically relevant, and capable of evolving responsibly over time.
Randi Wood, MB(ASCP)
Founder, Veridyn Diagnostics
Support the Research
We don’t have to wait to begin building stronger scientific foundations
Veridyn Diagnostics advances evidence-driven research to deepen understanding of gynecologic disease and support future progress in women’s health diagnostics.
Meaningful progress in women’s health diagnostics requires new models of support, particularly at early stages of research that often fall outside traditional funding structures.
This work moves forward through:
Scientific collaboration
Patient advocacy and education
Responsible research engagement
A shared commitment to advancing women’s health diagnostics
Progress begins with building the evidence.
Funds support early-stage research and research infrastructure.
Who We Are
Our mission
Veridyn Diagnostics is a scientist-led research initiative focused on building rigorous molecular evidence to advance understanding in women’s health and inform future progress in diagnostics.
We operate deliberately, prioritizing reproducibility, regulatory realism, and research approaches grounded in real-world clinical context. Our work draws from molecular biology, diagnostic science, and translational research principles.
This effort is focused on establishing a durable scientific foundation, one capable of supporting future advances as evidence accumulates, without shortcuts or premature commercialization.
Contact Us
Interested in working together? Share a few details and we’ll be in touch.
Contact:
contact@veridyndiagnostics.com